Paper31597366
Whole Tumor Histogram Analysis Using DW MRI in Primary Central Nervous System Lymphoma Correlates with Tumor Biomarkers and Outcome.
Chong I and 7 others. Cancers (Basel), 2019. Cited by 18 papers, by iCite.
Cite this record
ConductScience Library. Whole Tumor Histogram Analysis Using DW MRI in Primary Central Nervous System Lymphoma Correlates with Tumor Biomarkers and Outcome. Papers, record 31597366. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31597366
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Whole Tumor Histogram Analysis Using DW MRI in Primary Central Nervous System Lymphoma Correlates with Tumor Biomarkers and Outcome.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References35
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 23882093 | Apparent diffusion coefficient and beyond: what diffusion MR imaging can tell us about tissue structure. | Radiology | 2013 | https://conductscience.org/library/papers/23882093 | PubMed |
| 2 | 11214644 | Primary central nervous system lymphoma in AIDS: a wider spectrum of CT and MRI findings. | Neuroradiology | 2001 | https://conductscience.org/library/papers/11214644 | PubMed |
| 3 | 27341986 | Value of pretherapeutic DWI in evaluating prognosis and therapeutic effect in immunocompetent patients with primary central nervous system lymphoma given high-dose methotrexate-based chemotherapy: ADC-based assessment. | Clin Radiol | 2016 | https://conductscience.org/library/papers/27341986 | PubMed |
| 4 | 27490760 | Prognostic Significance of High Ki-67 Index and Histogenetic Subclassification in Primary Central Nervous System Lymphoma. | Appl Immunohistochem Mol Morphol | 2018 | https://conductscience.org/library/papers/27490760 | PubMed |
| 5 | 29113178 | Immunohistochemical profile and prognostic significance in primary central nervous system lymphoma: Analysis of 89 cases. | Oncol Lett | 2017 | https://conductscience.org/library/papers/29113178 | PubMed |
| 6 | 19186405 | Diffusion-weighted magnetic resonance imaging as a cancer biomarker: consensus and recommendations. | Neoplasia | 2009 | https://conductscience.org/library/papers/19186405 | PubMed |
| 7 | 15709118 | Spontaneous intracerebral hematoma on diffusion-weighted images: influence of T2-shine-through and T2-blackout effects. | AJNR Am J Neuroradiol | 2005 | https://conductscience.org/library/papers/15709118 | PubMed |
| 8 | 29200113 | Primary Central Nervous System Lymphoma. | Continuum (Minneap Minn) | 2017 | https://conductscience.org/library/papers/29200113 | PubMed |
| 9 | 22770690 | 3D Slicer as an image computing platform for the Quantitative Imaging Network. | Magn Reson Imaging | 2012 | https://conductscience.org/library/papers/22770690 | PubMed |
| 10 | 28099354 | Apparent diffusion coefficient normalization of normal liver: Will it improve the reproducibility of diffusion-weighted imaging at different MR scanners as a new biomarker? | Medicine (Baltimore) | 2017 | https://conductscience.org/library/papers/28099354 | PubMed |
| 11 | 22228634 | Immunochemotherapy with intensive consolidation for primary CNS lymphoma: a pilot study and prognostic assessment by diffusion-weighted MRI. | Clin Cancer Res | 2012 | https://conductscience.org/library/papers/22228634 | PubMed |
| 12 | 24240734 | Systems biology of primary CNS lymphoma: from genetic aberrations to modeling in mice. | Acta Neuropathol | 2014 | https://conductscience.org/library/papers/24240734 | PubMed |
| 13 | 15955902 | Report of an international workshop to standardize baseline evaluation and response criteria for primary CNS lymphoma. | J Clin Oncol | 2005 | https://conductscience.org/library/papers/15955902 | PubMed |
| 14 | 20616176 | Central nervous system lymphoma: characteristic findings on traditional and advanced imaging. | AJNR Am J Neuroradiol | 2011 | https://conductscience.org/library/papers/20616176 | PubMed |
| 15 | 22936096 | Combined diffusion and perfusion MR imaging as biomarkers of prognosis in immunocompetent patients with primary central nervous system lymphoma. | AJNR Am J Neuroradiol | 2013 | https://conductscience.org/library/papers/22936096 | PubMed |
| 16 | 27576949 | Impact of tissue sampling on accuracy of Ki67 immunohistochemistry evaluation in breast cancer. | Diagn Pathol | 2016 | https://conductscience.org/library/papers/27576949 | PubMed |
| 17 | 19729544 | Diffusion-weighted MR imaging derived apparent diffusion coefficient is predictive of clinical outcome in primary central nervous system lymphoma. | AJNR Am J Neuroradiol | 2010 | https://conductscience.org/library/papers/19729544 | PubMed |
| 18 | 21430371 | High Ki67 index and bulky disease remain significant adverse prognostic factors in patients with diffuse large B cell lymphoma before and after the introduction of rituximab. | Acta Haematol | 2011 | https://conductscience.org/library/papers/21430371 | PubMed |
| 19 | 23608829 | The Cleveland Clinic experience with primary central nervous system lymphoma. | Am J Clin Oncol | 2015 | https://conductscience.org/library/papers/23608829 | PubMed |
| 20 | 25393543 | Differentiation between primary cerebral lymphoma and glioblastoma using the apparent diffusion coefficient: comparison of three different ROI methods. | PLoS One | 2014 | https://conductscience.org/library/papers/25393543 | PubMed |
Cited by10
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 18 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42063134 | Prediction of relapsed/refractory primary central nervous system lymphoma using pre-chemotherapy ITSS grade on SWI and pre-/post-chemotherapy ADC parameters on DWI. | Cancer Imaging | 2026 | https://conductscience.org/library/papers/42063134 | PubMed |
| 41097746 | Radiomics-Based Detection of Germ Cell Neoplasia In Situ Using Volumetric ADC and FA Histogram Features: A Retrospective Study. | Cancers (Basel) | 2025 | https://conductscience.org/library/papers/41097746 | PubMed |
| 40028630 | Feasibility of ADC histogram analysis for predicting of postoperative recurrence in aggressive spinal tumors. | J Bone Oncol | 2025 | https://conductscience.org/library/papers/40028630 | PubMed |
| 39187807 | Prediction of PD-L1 and Ki-67 status in primary central nervous system diffuse large B-cell lymphoma by diffusion and perfusion MRI: a preliminary study. | BMC Med Imaging | 2024 | https://conductscience.org/library/papers/39187807 | PubMed |
| 38994341 | MRI radiomics-based interpretable model and nomogram for preoperative prediction of Ki-67 expression status in primary central nervous system lymphoma. | Front Med (Lausanne) | 2024 | https://conductscience.org/library/papers/38994341 | PubMed |
| 37511795 | Early MRI Predictors of Relapse in Primary Central Nervous System Lymphoma Treated with MATRix Immunochemotherapy. | J Pers Med | 2023 | https://conductscience.org/library/papers/37511795 | PubMed |
| 36354704 | Cranial Radiation Therapy as Salvage in the Treatment of Relapsed Primary CNS Lymphoma. | Curr Oncol | 2022 | https://conductscience.org/library/papers/36354704 | PubMed |
| 36010905 | An Overview of the Role of Multiparametric MRI in the Investigation of Testicular Tumors. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36010905 | PubMed |
| 35901353 | The Role of Pretherapeutic Diffusion-Weighted MR Imaging Derived Apparent Diffusion Coefficient in Predicting Clinical Outcomes in Immunocompetent Patients with Primary CNS Lymphoma: A Systematic Review and Meta-Analysis. | Asian Pac J Cancer Prev | 2022 | https://conductscience.org/library/papers/35901353 | PubMed |
| 33227089 | Diffusion-weighted MR imaging histogram analysis in HIV positive and negative patients with primary central nervous system lymphoma as a predictor of outcome and tumor proliferation. | Oncotarget | 2020 | https://conductscience.org/library/papers/33227089 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| SLC13A2 | 9058 | PubTator's text mining | https://conductscience.org/library/genes/9058 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/31597366
GET https://conductscience.org/api/papers/v1/31597366/references?page=2